MAPK3 and Miyoshi myopathy: We validated Erk1/2i + CDK4/6i signature-gene (G-set-1/2) expression in two independent MM patient cohorts (GDS4968 and GSE5900-2658), using previously described data analyses pipeline (Table S3) [45].